Surgery

Search results

• Weekly: Biohaven Pharmaceutical Holding (BHVN: $20.37) in top 1% performers of NYSE market in past week; +$3.24 [18.9%]

  Thomas, M.

  21/04/25

  1 item of Media coverage

  Press/Media

• Weekly: Collegium Pharmaceutical (COLL: $27.01) jumps 9% on below average volume; +$2.34 [9.5%]

  Thomas, M.

  21/04/25

  1 item of Media coverage

  Press/Media

• Weekly: Biohaven Pharmaceutical Holding (BHVN: $17.62) falls 5% - trailing 99% of stocks; -97c [5.2%] Vol Index 1.4 [1 is avg]

  Thomas, M.

  12/04/25

  1 item of Media coverage

  Press/Media

• Weekly: Collegium Pharmaceutical (COLL: $26.30) accelerates decline: down 11% in 2 weeks; -$1.84 [6.5%]

  Thomas, M.

  12/04/25

  1 item of Media coverage

  Press/Media

• Biohaven Pharmaceutical Holding tumbles 36% in 2025

  Thomas, M.

  7/04/25

  1 item of Media coverage

  Press/Media

• Collegium Pharmaceutical drops 23% in past year

  Thomas, M.

  7/04/25

  1 item of Media coverage

  Press/Media

• Biohaven Pharmaceutical Holding sinks 54% in past year, underperforming 98% of the market

  Thomas, M.

  7/04/25

  1 item of Media coverage

  Press/Media

• Collegium Pharmaceutical increases 4.2% in 2025, outperforming 81% of the market

  Thomas, M.

  7/04/25

  1 item of Media coverage

  Press/Media

• Weekly: Collegium Pharmaceutical (COLL: $28.14) shares post worst week in twenty weeks; -$1.57 [5.3%]

  Thomas, M.

  5/04/25

  1 item of Media coverage

  Press/Media

• Weekly: Biohaven Pharmaceutical Holding (BHVN: $18.59) in bottom 1% performers of NYSE market in past week; -$9.06 [32.8%] Vol Index 1.7 [1 is avg]

  Thomas, M.

  5/04/25

  1 item of Media coverage

  Press/Media

• Monthly: Collegium Pharmaceutical (COLL: $29.85) increases 3% on below average volume in March 2025

  Thomas, M.

  1/04/25

  1 item of Media coverage

  Press/Media

• Monthly: Biohaven Pharmaceutical Holding (BHVN: $24.04) in bottom 1% performers of NYSE market in March 2025

  Thomas, M.

  1/04/25

  1 item of Media coverage

  Press/Media

• Weekly: Biohaven Pharmaceutical Holding (BHVN: $27.65) falls for a fourth consecutive week, a four-week fall of 26%; -89c [3.1%]

  Thomas, M.

  29/03/25

  1 item of Media coverage

  Press/Media

• Weekly: Collegium Pharmaceutical (COLL: $29.71) decreases 1.1% on weak volume; -34c [1.1%]

  Thomas, M.

  29/03/25

  1 item of Media coverage

  Press/Media

• Weekly: Collegium Pharmaceutical (COLL: $30.05) up 3.9% in 2 weeks; +59c [2.0%] Vol Index 1.4 [1 is avg]

  Thomas, M.

  22/03/25

  1 item of Media coverage

  Press/Media

• Weekly: Biohaven Pharmaceutical Holding (BHVN: $28.54) drops 2.1% - trailing 95% of stocks; -61c [2.1%]

  Thomas, M.

  22/03/25

  1 item of Media coverage

  Press/Media

• Weekly: Biohaven Pharmaceutical Holding (BHVN: $29.15) down 22% in 2 weeks; -71c [2.4%]

  Thomas, M.

  15/03/25

  1 item of Media coverage

  Press/Media

• Weekly: Collegium Pharmaceutical (COLL: $29.46) shares post best week in nine weeks; +55c [1.9%]

  Thomas, M.

  15/03/25

  1 item of Media coverage

  Press/Media

• Biohaven Pharmaceutical Holding tumbles 24% in 2025, underperforming 89% of the market

  Thomas, M.

  14/03/25

  1 item of Media coverage

  Press/Media

• Collegium Pharmaceutical increases 1.6% in 2025

  Thomas, M.

  14/03/25

  1 item of Media coverage

  Press/Media

• Weekly: Collegium Pharmaceutical (COLL: $28.91) keeps sliding: down 13% in 7 weeks; -14c [0.5%]

  Thomas, M.

  8/03/25

  1 item of Media coverage

  Press/Media

• Weekly: Biohaven Pharmaceutical Holding (BHVN: $29.86) in bottom 2% performers of NYSE market in past week; -$7.32 [19.7%] Vol Index 1.3 [1 is avg]

  Thomas, M.

  8/03/25

  1 item of Media coverage

  Press/Media

• Biohaven Pharmaceutical Holding decreases 0.5% in 2025

  Thomas, M.

  4/03/25

  1 item of Media coverage

  Press/Media

• Collegium Pharmaceutical increases 1.4% in 2025

  Thomas, M.

  4/03/25

  1 item of Media coverage

  Press/Media

• Biohaven Pharmaceutical Holding plummets 21% in past year, underperforming 88% of the market

  Thomas, M.

  4/03/25

  1 item of Media coverage

  Press/Media